Max Healthcare Surges on Growth Outlook

  Published 11 months ago

Max Healthcare shares rise 2.4% as Jefferies boosts target to 1,400 rupees, citing 75% capacity expansion and 20% EBITDA growth.

  • Jefferies maintains a "buy" rating with a 1,400-rupee PT, 15% above the current price.
  • MAXE to expand beds to 9,000 in 3-4 years, driven by new units.
  • Stock up 7% YTD, outperforming peers Fortis (6%) and Apollo (down 4%).

You might like these

Prince Pipes FY25: Mixed Results & Future Outlook

Swiggy, Eternal Rally on Margin Hopes

Zaggle Expands With New Platform Deal

TCC Concept Acquires Pepperfry

Websol Stock Split & Solar Outlook

Tata Motors Falls JLR Shutdown Extends

Prime Focus Sees Big Investor Moves

News that matters the most ⚡